ArticleJournal for immunotherapy of cancer2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Yu Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.